,address1,address2,city,zip,country,phone,fax,website,longBusinessSummary,fullTimeEmployees,companyOfficers,maxAge,priceHint,previousClose,open,dayLow,dayHigh,regularMarketPreviousClose,regularMarketOpen,regularMarketDayLow,regularMarketDayHigh,beta,volume,regularMarketVolume,averageVolume,averageVolume10days,averageDailyVolume10Day,bid,ask,bidSize,askSize,marketCap,fiftyTwoWeekLow,fiftyTwoWeekHigh,priceToSalesTrailing12Months,fiftyDayAverage,twoHundredDayAverage,currency,enterpriseValue,profitMargins,floatShares,sharesOutstanding,heldPercentInsiders,heldPercentInstitutions,lastFiscalYearEnd,nextFiscalYearEnd,mostRecentQuarter,netIncomeToCommon,enterpriseToRevenue,enterpriseToEbitda,exchange,quoteType,symbol,underlyingSymbol,shortName,longName,firstTradeDateEpochUtc,timeZoneFullName,timeZoneShortName,gmtOffSetMilliseconds,currentPrice,recommendationKey,totalCash,totalCashPerShare,ebitda,totalDebt,quickRatio,currentRatio,totalRevenue,debtToEquity,revenuePerShare,returnOnEquity,grossProfits,operatingCashflow,revenueGrowth,grossMargins,ebitdaMargins,operatingMargins,financialCurrency,trailingPegRatio
0,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Mr. Yong Zu Kim', 'age': 66, 'title': 'CEO & Pres', 'yearBorn': 1956, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
1,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Mr. Sejin  Park', 'age': 60, 'title': 'Chief Financial Officer and VP', 'yearBorn': 1962, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
2,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Mr. Yeong Soo Oh', 'age': 63, 'title': 'Chief Technology Officer and Exec. VP', 'yearBorn': 1959, 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
3,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Mr. Jeiwook  Chae', 'title': 'Chief Bus. Devel. Officer', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
4,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Dr. Young-Lag  Cho Ph.D.', 'title': 'Chief Devel. Officer & Head Researcher & Devel.', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
5,"10, Gukjegwahak 10-ro",Yuseong-gu,Daejeon,34002,South Korea,82 4 2861 0688,82 4 2861 0689,https://www.legochembio.com,"LegoChem Biosciences, Inc. a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, and oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It offers its products in the forms of tablets and capsules. The Company also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea.",137,"{'maxAge': 1, 'name': 'Dr. Chul-Woong  Chung', 'title': 'Head of ADC Center', 'exercisedValue': 0, 'unexercisedValue': 0}",86400,2,39650.0,40250.0,38750.0,40950.0,39650.0,40250.0,38750.0,40950.0,0.628639,353714,353714,264563,471879,471879,39050.0,39100.0,0,0,418154217472,30050.0,46000.0,11.857285,35445.0,37979.0,KRW,797171056640,-1.54076,23433070,10599600,0.11079001,0.11817,1672444800,1703980800,1680220800,-54335692800,22.605,-14.473,KOE,EQUITY,141080.KQ,141080.KQ,LegoChem Bio,"LegoChem Biosciences, Inc.",1368144000,Asia/Seoul,KST,32400000,39450.0,none,149417132032,5657.277,-55080640512,12199668736,5.967,6.075,35265597440,6.042,1417.889,-0.23587999,17848689560,-28401504256,0.319,0.54188,-1.56188,-1.6842799,KRW,
